OS (OneStream, Inc. Class A Common Stock) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

OS does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for OS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for OS and 80,000+ other tickers.
See exactly how OS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OS and 80,000+ other tickers.
OneStream, Inc. delivers an integrated, adaptable software platform, enhanced with artificial intelligence capabilities, to clients across the United States and internationally. Their flagship offering, the Digital Finance Cloud platform, provides essential solutions for modern financial management. These include simplifying financial close and consolidation by automating various tasks and expertly navigating the intricate requirements and standards of financial reporting. The platform also supports comprehensive financial and operational planning, budgeting, forecasting, and detailed results…

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the publication of primary analysis results from the global Phase III HARMONi clinical trial in The Lanc

AstraZeneca (AZN) is trading relatively stable after announcing two encouraging Phase III updates for lung cancer treatments, which somewhat mitigated a setback

Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combi

Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) demonstrated a statistically significan

Gabelli Funds LLC bought a new stake in shares of OneStream, Inc. (NASDAQ: OS) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 523,583 shares of the company's stock, valued at approximately $12,566,000. Gabelli Funds LLC owned approximately 0.21%